Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H (3) receptor antagonists.
Department R4MN, AP9A-3, Abbott Laboratories, Global Pharmaceutical Research and Development, 100 Abbott Park Road, Abbott Park, IL, 60064-6125, USA.
A A
AA
Hancock
R S
RS
Bitner
K M
KM
Krueger
S
S
Otte
A L
AL
Nikkel
T A
TA
Fey
E N
EN
Bush
R W
RW
Dickinson
R
R
Shapiro
V
V
Knourek-Segel
B A
BA
Droz
M E
ME
Brune
P B
PB
Jacobson
M D
MD
Cowart
T A
TA
Esbenshade
D000818:Animals; D019440:Anti-Obesity Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003071:Cognition / Q000187:drug effects*; D006633:Histamine Antagonists / Q000494:pharmacology*; D008024:Ligands; D008297:Male; D051379:Mice; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018100:Receptors, Histamine H3 / Q000187:drug effects*
D019440:Anti-Obesity Agents; D006633:Histamine Antagonists; D008024:Ligands; D016760:Proto-Oncogene Proteins c-fos; D018100:Receptors, Histamine H3